0240 GMT - The a2 Milk Company's bull at Citi sees the infant-formula maker's December-half result as more evidence that headwinds in China against overseas providers have dissipated. Gone are the days in which market-share gains are dominated by domestic brands, analyst Sam Teeger says. Reiterating his buy recommendation, Teeger tells clients in a note that a2 Milk is the third highest market-share gainer in China, trailing Nestle and China's Yili. Three of the top five brands are now from outside China, he observes. He sees a2 Milk gearing up for a strong fiscal 2026, with share-price catalysts including potential government stimulus, supply chain acquisitions, and capital management. Citi raises its target price 12% to A$8.20. Shares are up 2.7% at A$7.315. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 17, 2025 21:40 ET (02:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.